Castres
,
April 12, 2023
(press release)
–
MÊME, the first dermo-cosmetic brand for patients experiencing the side effects of cancer treatments Today, the Pierre Fabre Group announced the acquisition of the MÊME brand launched in 2017 by Judith Levy Keller and Juliette Couturier, who will continue to manage the company. MÊME has won over the hearts of people affected by cancer by offering the first skin, scalp and nail care range, developed in collaboration with oncologists and dermatologists, to address the side effects of cancer treatments. A minority shareholder for 5 years, Pierre Fabre has today acquired the entire capital of MÊME from the co-founders and the Eutopia investment fund specializing in “emerging consumer brands”, via its Otium Consumer fund. MÊME was born following the painful personal experiences of the co-founders. Judith Levy and Juliette Couturier have first-hand experience of the physical (adverse effects on the skin, mucous membranes and hair) and psychological difficulties that cancer patients often encounter both during and after their treatments. They refused to accept defeat and created a range of dermo-cosmetic care products and make-up based on natural ingredients, with formulas that have been tested to guarantee tolerance and efficacy. These products, made in France, are developed with a single conviction: taking care of yourself and your skin means being better equipped to accept treatment and fight against the disease. This story seduced the investment fund Eutopia, which, in January 2016, had invested in the project via its Otium Consumer fund, to finance the first clinical trials. The acquisition of MÊME by Pierre Fabre signals the continuation of the commercial partnership signed in December 2017. For 3 years, the sales network of the Eau Thermale Avène brand introduced the philosophy and products of MÊME in pharmacies and drugstores. Today, MÊME offers a rich catalog of 46 products, in 4,800 pharmacies and drugstores, as well as on its online sales site. The brand is already distributed in 10 other countries (Germany, Belgium, Switzerland, Morocco, Romania, Czech Republic, Ireland, Spain, Italy and, more recently, China) with significant potential for growth in numerous markets. About MÊME Launched online in 2017 as a DNVB, MÊME has been able to use digital leverage to build a genuine relationship of intimacy and trust with its consumers, with whom it has co-created all its products. Thanks to its effective formulas tested in clinical studies conducted in major French oncology departments, the brand has quickly become a success with people whose skin has been weakened by treatments and who are looking for hypoallergenic, highly natural products, but above all, free of any controversial ingredients. The quality of the products has also led to strong demand from pharmacists, for whom MÊME has become the reference brand for meeting the needs of cancer patients. The brand and its 46 products manufactured in France are now distributed in 4,800 pharmacies, drugstores and committed retailers in France and 10 other countries. In addition to its products, MÊME has adopted a holistic approach to a subject that was previously largely taboo and offers its customers a solid community of support on social networks, a blog that has become a reference for patients and their loved ones, a podcast "Danser sous la pluie" (Dancing in the Rain) that looks at cancer from a different perspective, and information workshops in hundreds of oncology departments. Committed to the fight against "the disease of the century", the company has donated 1% of its sales to cancer research since its creation. About the Pierre Fabre Group Pierre Fabre is the 2nd largest dermo-cosmetic laboratory in the world and the 2nd largest private French pharmaceutical group. Its portfolio includes numerous medical franchises and international brands such as Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Darrow, Glytone, Naturactive , Elgydium, Inava and Arthrodont. In 2022, Pierre Fabre recorded turnover of €2.7 billion, 69% of which was generated internationally in some 120 countries, and invested more than €170 million in R&D. The group has always been based in the Occitanie region of France and manufactures 90% of its products in France. It employs nearly 9,600 people worldwide. Pierre Fabre is 86% owned by the Pierre Fabre Foundation, a foundation recognized as being of public interest since 1999, and secondarily by its employees through an employee shareholding plan. En 2022, la démarche RSE du Groupe est évaluée par l’organisme indépendant AFNOR Certification au niveau « Exemplaire » du label Engagé RSE (norme ISO 26 000 du développement durable). www.pierre-fabre.com, @PierreFabre
www.memecosmetics.fr @memecosmetics
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
